Evidence map›Paper›PMID 19956647›Full record

ArticlePloS one2009

Expression of an IKKgamma splice variant determines IRF3 and canonical NF-kappaB pathway utilization in ssRNA virus infection.

Ping Liu, Muping Lu, Bing Tian, Kui Li, Roberto P Garofalo, Deborah Prusak, Thomas G Wood, Allan R Brasier

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 32 citations in OpenAlex.

  1. Viral Modulation of Host Splicing.Annual review of virology · 2025
    Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ping LiuDepartment of Medicine, University of Texas Medical Branch (UTMB), Galveston, Texas, United States of America.
Muping Lu
Bing Tian
Kui Li
Roberto P Garofalo
Deborah Prusak
Thomas G Wood
Allan R Brasier
The University of Texas Medical Branch at Galveston · USUniversity of Tennessee Health Science Center · US

Funding

Virus, Tissue Culture and ImmunoassayP01AI062885 · NIAID · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI BOLDOGH, ISTVAN STEVEN · 2005 to 2022
$23.9M
Synthetic Organic Chemistry CoreP30ES006676 · NIEHS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI ELFERINK, CORNELIS JOHAN · 1995 to 2017
$21.7M
Collaborative Research : Stochastic Modeling and Estimation of Gene TranscriptionR01GM086885 · NIGMS · RICE UNIVERSITY · PI KIMMEL, MAREK · 2008 to 2011
$1.7M
NHLBI PROTEOMICS INITIATIVE-N01HV28184N01HV028184 · HV · UNIV OF TEXAS MEDICAL BRANCH · PI KUROSKY, ALEXANDER NONE · 2002 to 2006
–
NHLBI NIH HHS N01 HV028184NHLBI NIH HHS N01-HV-28184NIAID NIH HHS P01 AI062885NIEHS NIH HHS P30 ES006676NIEHS NIH HHS P30 ES06676NIGMS NIH HHS R01 GM086885
6 · The paper itself

Abstract

unlabelledSingle stranded RNA (ssRNA) virus infection activates the retinoic acid inducible gene I (RIG-I)- mitochondrial antiviral signaling (MAVS) complex, a complex that coordinates the host innate immune response via the NF-kappaB and IRF3 pathways. Recent work has shown that the IkappaB kinase (IKK)gamma scaffolding protein is the final common adapter protein required by RIG-I.MAVS to activate divergent rate-limiting kinases downstream controlling the NF-kappaB and IRF3 pathways. Previously we discovered a ubiquitous IKKgamma splice-variant, IKKgammaDelta, that exhibits distinct signaling properties. METHODOLOGY/PRINCIPAL

findingsWe examined the regulation and function of IKKgamma splice forms in response to ssRNA virus infection, a condition that preferentially induces full length IKKgamma-WT mRNA expression. In IKKgammaDelta-expressing cells, we found increased viral translation and cytopathic effect compared to those expressing full length IKKgamma-WT. IKKgammaDelta fails to support viral-induced IRF3 activation in response to ssRNA infections; consequently type I IFN production and the induction of anti-viral interferon stimulated genes (ISGs) are significantly attenuated. By contrast, ectopic RIG-I.MAVS or TNFalpha-induced canonical NF-kappaB activation is preserved in IKKgammaDelta expressing cells. Increasing relative levels of IKKgamma-WT to IKKgammaDelta (while keeping total IKKgamma constant) results in increased type I IFN expression. Conversely, overexpressing IKKgammaDelta (in a background of constant IKKgamma-WT expression) shows IKKgammaDelta functions as a dominant-negative IRF3 signaling inhibitor. IKKgammaDelta binds both IKK-alpha and beta, but not TANK and IKKepsilon, indicating that exon 5 encodes an essential TANK binding domain. Finally, IKKgammaDelta displaces IKKgammaWT from MAVS explaining its domainant negative effect. CONCLUSIONS/SIGNIFICANCE: Relative endogenous IKKgammaDelta expression affects cellular selection of inflammatory/anti-viral pathway responses to ssRNA viral infection.

Indexed as

Alternative SplicingAnimalsCell Line, TumorFibroblastsGenes, DominantHumansI-kappa B KinaseInterferon Regulatory Factor-3MiceMicroscopy, FluorescenceModels, BiologicalNF-kappa BRNA VirusesRNA Virus InfectionsSignal TransductionI-kappa B KinaseInterferon Regulatory Factor-3IRF3 protein, humanIrf3 protein, mouseNF-kappa B

Identifiers

PMID19956647
PMCPMC2778955
OpenAlexW2089808584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.